Anika Therapeutics Inc (NASDAQ:ANIK)

38.35
Delayed Data
As of Apr 24
 -0.32 / -0.83%
Today’s Change
34.16
Today|||52-Week Range
51.40
-5.87%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues64.8M71.4M75.1M105.6M
 
 
 
 
 
Cost of Goods Sold22.8M24.5M18.0M16.2M
 
 
 
 
 
Depreciation And Amortization4.0M4.5M4.8M4.7M
 
 
 
 
 
 
Operating ExpensesGross Income38.0M42.4M52.3M84.7M
 
 
 
 
 
General Expenses24.0M20.1M20.0M23.2M
 
 
 
 
 
Research And Development6.2M5.4M7.1M8.1M
 
 
 
 
 
Total Operating Expenses50.8M49.1M42.8M44.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income14.0M22.3M32.3M61.4M
 
 
 
 
 
Extraordinary Credit0.000.00286.8K0.00
 
 
Extraordinary Charge0.00-2.5M0.000.00
 
 
Interest Expense On Debt182.4K187.8K127.2K0.00
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income13.8M19.5M32.5M61.5M
 
 
 
 
 
Income Taxes-5.3M-7.8M-11.9M-23.2M
 
 
 
 
 
Net Income8.5M11.8M20.6M38.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS13.1M13.3M14.1M14.7M
 
 
 
 
 
Shares To Calculate EPS Diluted13.7M14.3M14.8M15.3M
 
 
 
 
 
 
Earnings Per ShareEPS$0.62$0.82$1.39$2.51
 
 
 
 
 
EPS Diluted$0.62$0.82$1.39$2.51
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account